FGF21 prevented acute hyperlipidemia-induced renal dysfunction. FVB mice were injected intraperitoneally BSA-FA (10 mg/g) with or without simultaneous administration of FGF21 (100 μg/kg) for 10 days (Table 1). Here, FGF21 is linked to hyperlipidemia.